Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors (2020)
- Authors:
- Autor USP: MUSSI, MARISA MARCIA - FMRP
- Unidade: FMRP
- DOI: 10.1371/journal.pone.0242405
- Subjects: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE; FARMACOTERAPIA; PEDIATRIA; HIV; CRIANÇAS
- Keywords: Antiretroviral therapy; Protease inhibitor therapy; Drug therapy; Protease inhibitors; Pediatrics; Reverse transcriptase inhibitors; Questionnaires; Drug adherence
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2020
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
YIN, Dwight E. et al. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, v. 15, n. 11, p. 1-18, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0242405. Acesso em: 21 jan. 2026. -
APA
Yin, D. E., Ludema, C., Cole, S. R., Golin, C. E., Miller, W. C., Warshaw, M. G., et al. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLOS ONE, 15( 11), 1-18. doi:10.1371/journal.pone.0242405 -
NLM
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1371/journal.pone.0242405 -
Vancouver
Yin DE, Ludema C, Cole SR, Golin CE, Miller WC, Warshaw MG, McKinney Jr. RE, Mussi-Pinhata MM. Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors [Internet]. PLOS ONE. 2020 ; 15( 11): 1-18.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1371/journal.pone.0242405 - Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Latin America and the Caribbean: the NIDSI perinatal study
- Knowledge and practice of prechewing/ prewarming food by HIV-infectede women
- Challenges in the implementation of the NeoOBS study, a global pragmatic observational cohort study, to investigate the aetiology and management of neonatal sepsis in the hospital setting
- Influencia da epoca de aplicacao da vacina bcg intradermica em criancas com e sem retardo do crescimento intra-utero na hipersensibilidade tuberculinica pos-vacinal
- Particularidades imunológicas do pré-termo extremo: um desafio para a prevenção da sepse hospitalar
- Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected pregnant women and adverse infant outcomes
- Infecções neonatais hospitalares
- Correlates of neonatal infectious disease morbidity in HIV: uninfected infants born to HIV-infected Latin American and Caribbean Mothers
- Prechewing and prewarming food for HIV-exposed children [Carta]: a prospective cohort experience from Latin America
- Lower respiratory tract infections and hospitalizations among HIV-exposed, uninfected infants born in Latin America
Informações sobre o DOI: 10.1371/journal.pone.0242405 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003048359.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
